Literature DB >> 8626563

In vitro interaction between human immunodeficiency virus type 1 Rev protein and splicing factor ASF/SF2-associated protein, p32.

T O Tange1, T H Jensen, J Kjems.   

Abstract

Continuous replication of human immunodeficiency virus type 1 requires the expression of the regulatory protein Rev, which binds to the Rev response element (RRE) and up-regulates the cytoplasmic appearance of singly spliced and unspliced mRNA species. It has been demonstrated that the murine protein YL2 interacts with Rev in vivo and modulates the activity of Rev (Luo, Y., Yu, H., and Peterlin, B. M. (1994) J. Virol. 68, 3850-3856). Here we show that the YL2 human homologue, the p32 protein, which co-purifies with alternative splicing factor ASF/SF2, interacts directly with the basic domain of Rev in vitro and that the Rev-p32 complex is resistant to high concentrations of salt or nonionic detergent. Protein footprinting data suggest that Rev interacts specifically with amino acids within the 196-208 region of p32. An analysis of the ternary complex, formed among p32, Rev, and RRE RNA, shows that Rev can bridge the association of p32 and RRE. Furthermore, we demonstrate that exogenously added p32 specifically relieves the inhibition of splicing in vitro exerted by the basic domain of Rev. Our data are consistent with a model in which p32 functions as a link between Rev and the cellular splicing apparatus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626563     DOI: 10.1074/jbc.271.17.10066

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  The trypanosome homolog of human p32 interacts with RBP16 and stimulates its gRNA binding activity.

Authors:  M L Hayman; M M Miller; D M Chandler; C C Goulah; L K Read
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

2.  The Herpesvirus Saimiri open reading frame 73 gene product interacts with the cellular protein p32.

Authors:  Kersten T Hall; Mathew S Giles; Michael A Calderwood; Delyth J Goodwin; David A Matthews; Adrian Whitehouse
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Truncated variants of hyaluronan-binding protein 1 bind hyaluronan and induce identical morphological aberrations in COS-1 cells.

Authors:  Aniruddha Sengupta; Rakesh K Tyagi; Kasturi Datta
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

4.  In vitro and in vivo interactions between the hepatitis B virus protein P22 and the cellular protein gC1qR.

Authors:  S Lainé; A Thouard; J Derancourt; M Kress; D Sitterlin; J-M Rossignol
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

5.  RNA-protein interactions of an archaeal homotetrameric splicing endoribonuclease with an exceptional evolutionary history.

Authors:  J Lykke-Andersen; R A Garrett
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

6.  An acidic protein, YBAP1, mediates the release of YB-1 from mRNA and relieves the translational repression activity of YB-1.

Authors:  Ken Matsumoto; Kimio J Tanaka; Masafumi Tsujimoto
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

7.  Protein footprinting approach to mapping DNA binding sites of two archaeal homing enzymes: evidence for a two-domain protein structure.

Authors:  J Lykke-Andersen; R A Garrett; J Kjems
Journal:  Nucleic Acids Res       Date:  1996-10-15       Impact factor: 16.971

8.  Interactions between RNA-binding proteins and P32 homologues in trypanosomes and human cells.

Authors:  Juan Manuel Polledo; Gabriela Cervini; María Albertina Romaniuk; Alejandro Cassola
Journal:  Curr Genet       Date:  2015-09-18       Impact factor: 3.886

9.  Human p32, interacts with B subunit of the CCAAT-binding factor, CBF/NF-Y, and inhibits CBF-mediated transcription activation in vitro.

Authors:  Chandrani Chattopadhyay; David Hawke; Ryuji Kobayashi; Sankar N Maity
Journal:  Nucleic Acids Res       Date:  2004-07-08       Impact factor: 16.971

10.  Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32.

Authors:  Reem Berro; Kylene Kehn; Cynthia de la Fuente; Anne Pumfery; Richard Adair; John Wade; Anamaris M Colberg-Poley; John Hiscott; Fatah Kashanchi
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.